Micron Breaches 1 Trillion Market Cap Milestone as AIDriven Memory Shortage Lifts Stock 19 Amazon Faces Allegations Over Millions in Revenue from NowIllegal Policy SpaceX Faces A Crucial Launch Test Ahead Of Its IPO Diving Equipment Industry Under Scrutiny Following Italian Cave Tragedy EasyJet Faces Italian Probe Over Baggage Pricing Practices US Private Payrolls Rise 109000 in April Exceeding Expectations ADP Report RMBI Q1 2026 Earnings Solid EPS Amid Quiet Quarter Stock Edges Lower Electrovaya Inc Q1 2026 Earnings EPS Beats Estimates by 307 Stock Gains 207 DTG Q1 2026 Earnings EPS Miss Modest Stock Decline Amid Mixed Signals OXM Q1 2026 Earnings A Significant Earnings Miss Amid Strategic Adjustments UTHR Q1 2026 Earnings EPS Misses Estimates as Operational Costs Weigh on Results Diebold Nixdorf DBD Q1 2026 Earnings EPS Beat Drives Modest Stock Upside Bank of the James Financial Group BOTJ Sees Minor Decline as Shares Test Near Support First Guaranty Bancshares Preferred FGBIP Edges Lower as Consolidation Continues MFA Financial Inc MFA Edges Lower as Stock Nears Key Support Level Calamos Global Total Return Fund CGO Advances 192 Testing Key Resistance Zone Evogene EVGN Slides 3 as Shares Test Key Support Near 066 Ultra Clean Holdings UCTT Surges 471 as Semiconductor Sector Momentum Builds Nano Dimension NNDM Nears Support Amid Slight Decline Key Levels in Focus SC II Acquisition Corp Edges Higher Amid Light Trading Near Key Support Deutsche Bank DB Edges Lower Amid Market Uncertainty Key Levels to Watch WESCO International WCC Climbs 26 as Price Approaches Key Resistance LFMDP Preferred Stock Edges Higher Amid Steady Preferred Market Sentiment Standard Chartered CEO Apologizes for Lower Value Human Capital Remark Omnicell Inc OMCL Q1 2026 Earnings EPS Surges Past Estimates Stock Slips FACT II Acquisition Corp Unit FACTU Holds Steady Near 1145 SPAC Unit Consolidates Amid Low Volatility Western Copper and Gold Corporation WRN Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Development Stage WDS Q4 2025 Earnings EPS Surges 338 Above Estimates on Strong Operational Performance Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 OM Q1 2026 Earnings EPS Misses Estimates as Outset Medical Posts WiderThanExpected Loss Stock Edges Up MSEX Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher Dominari Holdings Inc DOMH Q1 2024 Earnings Reports GAAP Loss of 035 Per Share Amid Flat Revenue MGYR Q4 2025 Earnings EPS of 040 Reported Stock Unchanged